GSK - four awards
GlaxoSmithKline's (GSK's) Sri Lanka operations, encompassing
pharmaceuticals and consumer nutritionals, won four National Business
Excellence Awards (NBEAs) at the 2015 edition of the awards event of the
National Chamber of Commerce, including the overall runner-up award
across all categories and sectors.
Equalling its performance last year, GSK won the Gold for
'Performance Management' in the Criteria Awards, the Gold for
'Healthcare Related Services' in the Sector Awards, the Silver in the
'Extra Large Category' in the Category Awards across all sectors, in
addition to its Silver in the 'Overall Winners' group.
Ninety-two awards were presented to 62 shortlisted companies in 29
sectors of business at the National Business Excellence Awards,
presented for the 12th consecutive year. For GSK, 2015 was its second
year of participation in the awards program.
Managing Director, GSK Pharmaceuticals in Sri Lanka, Stuart Chapman
said, "Being adjudged the second overall for business excellence among
companies in diverse areas of business is an excellent affirmation of
the balanced, socially-responsible performance model of GSK.
"The multi-dimensional evaluation for these awards emphasises that
business is not just about doing well, it is also about doing it right.
We are, therefore, greatly encouraged by the endorsement of the eminent
panel of judges for these awards," he said.
Winners of National Business Excellence Awards are assessed to a
marking scheme that encompasses Excellence in Leadership, Excellence in
Corporate Governance, Excellence in Capacity Building, Excellence in
Performance Management, Excellence in Local and Global Market Reach.
In January this year, GSK Pharmaceuticals adopted a new sales force
remuneration program in Sri Lanka, eliminating individual sales targets.
The new remuneration methodology is based on the core principle that GSK
Pharmaceuticals will not link remuneration to individual sales
representatives with the achievement of sales targets.